Literature DB >> 21442460

Surviving stiff-person syndrome: a case report.

Sharmilee Gnanapavan, Angela Vincent, Gavin Giovannoni.   

Abstract

Stiff-person syndrome (SPS) is a rare condition of progressive muscular rigidity and spasm, frequently accompanied by other autoimmune conditions, an association which has been further strengthened by the discovery of anti-GAD antibodies and the response of SPS to immunotherapies. Intravenous immunoglobulin (IVIg) is the mainstay therapy. Because of the rarity of the GAD antibody associated conditions, most of the information regarding treatment is case series and individual case reports. Here we describe the 15 year long management of a subject with SPS who has had a favourable outcome.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21442460     DOI: 10.1007/s00415-011-6015-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  8 in total

1.  The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome.

Authors:  M C Dalakas; M Fujii; M Li; B McElroy
Journal:  Neurology       Date:  2000-11-28       Impact factor: 9.910

2.  Progressive fluctuating muscular rigidity and spasm ("stiff-man" syndrome); report of a case and some observations in 13 other cases.

Authors:  F P MOERSCH; H W WOLTMAN
Journal:  Proc Staff Meet Mayo Clin       Date:  1956-07-25

3.  Treatment of stiff person syndrome with rituximab.

Authors:  M R Baker; M Das; J Isaacs; P R W Fawcett; D Bates
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

4.  High-dose intravenous immune globulin for stiff-person syndrome.

Authors:  M C Dalakas; M Fujii; M Li; B Lutfi; J Kyhos; B McElroy
Journal:  N Engl J Med       Date:  2001-12-27       Impact factor: 91.245

5.  Antibodies to 125I-glutamic acid decarboxylase in patients with stiff man syndrome.

Authors:  A Vincent; L M Grimaldi; G Martino; C Davenport; I Todd
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-04       Impact factor: 10.154

6.  Stiff-person syndromes: motor cortex hyperexcitability correlates with anti-GAD autoimmunity.

Authors:  Claudia Koerner; Bettina Wieland; Wiltrud Richter; Hans-Michael Meinck
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

7.  Rituximab, B-lymphocyte depletion, and preservation of beta-cell function.

Authors:  Mark D Pescovitz; Carla J Greenbaum; Heidi Krause-Steinrauf; Dorothy J Becker; Stephen E Gitelman; Robin Goland; Peter A Gottlieb; Jennifer B Marks; Paula F McGee; Antoinette M Moran; Philip Raskin; Henry Rodriguez; Desmond A Schatz; Diane Wherrett; Darrell M Wilson; John M Lachin; Jay S Skyler
Journal:  N Engl J Med       Date:  2009-11-26       Impact factor: 91.245

8.  Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome.

Authors:  H R Brashear; L H Phillips
Journal:  Neurology       Date:  1991-10       Impact factor: 9.910

  8 in total
  3 in total

1.  Paraneoplastic neurological syndromes: general treatment overview.

Authors:  Aurélien Viaccoz; Jérôme Honnorat
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

2.  A complex case of anti-GAD antibody-related syndrome treated with Rituximab.

Authors:  D Baroncini; F Spagnolo; L Sarro; G Comi; M A Volonte'
Journal:  Neurol Sci       Date:  2013-02-13       Impact factor: 3.307

Review 3.  Clinical Spectrum of Stiff Person Syndrome: A Review of Recent Reports.

Authors:  Harini Sarva; Andres Deik; Aman Ullah; William L Severt
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2016-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.